Overall, 60.2% of patients with AH and CHD received aspirin, 61.5% statins, 81.9% ACE inhibitors, 58.9% beta-blockers, 26.3% calcium channel blockers, 50.3% diuretics, 7.3% anticoagulants and 4.3% glucose lowering drugs. Here, ACE is linked to coronary artery disorder.